4588.T
Price:
$923
Market Cap:
$22.93B
Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States. Its product pipeline includes Telomelysin (OBP-301), an oncolytic adenovirus that is in phase II clinical trial for the treatment of gastric cancer/gastroesophageal junction, head and neck, and esophageal cancers; and in phase I clinical trial for the treatment of hepatocellular carcinoma. The company's product pipeline also includes OBP-702, a telomerase-specific oncolytic adenovirus, which is in pre-clinical trial for the treatment of solid tumors; OBP-2011, which is in pr...[Read more]
Industry
Biotechnology
IPO Date
2013-12-06
Stock Exchange
JPX
Ticker
4588.T
According to Oncolys BioPharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 21.91B. This represents a change of 72.73% compared to the average of 12.69B of the last 4 quarters.
The mean historical Enterprise Value of Oncolys BioPharma Inc. over the last ten years is 10.34B. The current 21.91B Enterprise Value has changed 21.09% with respect to the historical average. Over the past ten years (40 quarters), 4588.T's Enterprise Value was at its highest in in the June 2020 quarter at 43.30B. The Enterprise Value was at its lowest in in the September 2015 quarter at 1.71B.
Average
10.34B
Median
8.59B
Minimum
2.74B
Maximum
23.95B
Discovering the peaks and valleys of Oncolys BioPharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 183.35%
Maximum Annual Enterprise Value = 23.95B
Minimum Annual Increase = -69.38%
Minimum Annual Enterprise Value = 2.74B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 9.47B | 3.83% |
| 2023 | 9.12B | 13.15% |
| 2022 | 8.06B | 29.46% |
| 2021 | 6.23B | -69.38% |
| 2020 | 20.33B | -15.10% |
| 2019 | 23.95B | 136.14% |
| 2018 | 10.14B | 80.91% |
| 2017 | 5.61B | -27.73% |
| 2016 | 7.76B | 183.35% |
| 2015 | 2.74B | -7.48% |
The current Enterprise Value of Oncolys BioPharma Inc. (4588.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.88B
5-year avg
10.64B
10-year avg
10.34B
Oncolys BioPharma Inc.’s Enterprise Value is greater than StemRIM (8.79B), greater than CanBas Co., Ltd. (12.74B), greater than Japan Tissue Engineering Co., Ltd. (16.46B), less than Astena Holdings Co., Ltd. (28.19B), greater than CellSeed Inc. (7.84B), less than Fuso Pharmaceutical Industries,Ltd. (43.36B), greater than ReproCELL Incorporated (12.17B), less than RaQualia Pharma Inc. (27.39B), greater than MediciNova, Inc. (42.55M), less than Ohki Healthcare Holdings Co.,Ltd. (29.30B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 8.79B | $15.78B | |
| 12.74B | $15.57B | |
| 16.46B | $20.39B | |
| 28.19B | $18.41B | |
| 7.84B | $9.36B | |
| 43.36B | $18.29B | |
| 12.17B | $14.87B | |
| 27.39B | $27.61B | |
| 42.55M | $11.53B | |
| 29.30B | $19.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolys BioPharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncolys BioPharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oncolys BioPharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Oncolys BioPharma Inc. (4588.T)?
What is the 3-year average Enterprise Value for Oncolys BioPharma Inc. (4588.T)?
What is the 5-year average Enterprise Value for Oncolys BioPharma Inc. (4588.T)?
How does the current Enterprise Value for Oncolys BioPharma Inc. (4588.T) compare to its historical average?